Skip to main content
PortfolioRapha Capital Management

3DBio Therapeutics Receives Orphan Drug Designation for AuriNovo™ for Ear Reconstruction in Microtia Patients

By November 19, 2019February 4th, 2021No Comments

Leave a Reply